Compare VERA & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | WEN |
|---|---|---|
| Founded | 2016 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2021 | N/A |
| Metric | VERA | WEN |
|---|---|---|
| Price | $46.59 | $8.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 21 |
| Target Price | ★ $76.60 | $10.11 |
| AVG Volume (30 Days) | 1.1M | ★ 5.5M |
| Earning Date | 02-25-2026 | 02-13-2026 |
| Dividend Yield | N/A | ★ 6.73% |
| EPS Growth | N/A | ★ 0.63 |
| EPS | N/A | ★ 0.95 |
| Revenue | N/A | ★ $2,208,190,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.01 |
| P/E Ratio | ★ N/A | $8.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.53 | $7.83 |
| 52 Week High | $56.05 | $16.20 |
| Indicator | VERA | WEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 47.85 |
| Support Level | $45.02 | $8.30 |
| Resistance Level | $49.75 | $8.70 |
| Average True Range (ATR) | 2.51 | 0.29 |
| MACD | -0.98 | 0.02 |
| Stochastic Oscillator | 18.54 | 35.38 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.